102 related articles for article (PubMed ID: 17291633)
1. [Multisystemic amyloidosis in 2007].
Grateau G; Valleix S; Callard P
Rev Med Interne; 2007 May; 28(5):281-3. PubMed ID: 17291633
[No Abstract] [Full Text] [Related]
2. Advances in the treatment of amyloidosis.
Rajkumar SV; Gertz MA
N Engl J Med; 2007 Jun; 356(23):2413-5. PubMed ID: 17554124
[No Abstract] [Full Text] [Related]
3. [New trends in the treatment of amyloidosis].
Martínez-Valle F; Gironella-Mesa M; Solans-Laqué R
Med Clin (Barc); 2012 May; 138(15):667-72. PubMed ID: 22197598
[TBL] [Abstract][Full Text] [Related]
4. AA cardiomyopathy.
Dasgupta NR; Cummings OW; Phillips CL; Benson MD
Amyloid; 2017 Mar; 24(sup1):138-139. PubMed ID: 28434308
[No Abstract] [Full Text] [Related]
5. [A new treatment of renal disease in AA amyloidosis...and not only that?].
Pani A
G Ital Nefrol; 2008; 25(1):12. PubMed ID: 18264913
[No Abstract] [Full Text] [Related]
6. Eprodisate in AA amyloidosis.
Manenti L; Tansinda P; Vaglio A
N Engl J Med; 2007 Sep; 357(11):1153; author reply 1153-4. PubMed ID: 17855678
[No Abstract] [Full Text] [Related]
7. Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients.
Kumar S; Murray D; Dasari S; Milani P; Barnidge D; Madden B; Kourelis T; Arendt B; Merlini G; Ramirez-Alvarado M; Dispenzieri A
Leukemia; 2019 Jan; 33(1):254-257. PubMed ID: 29977017
[No Abstract] [Full Text] [Related]
8. [New possibilities of the diagnosis and monitoring of the course of AL-amyloidosis].
Rameev VV; Kozlovskaia LV; Kogarko IN; Kogarko BS
Ter Arkh; 2010; 82(6):29-32. PubMed ID: 20731106
[TBL] [Abstract][Full Text] [Related]
9. Recognizing Pinch Purpura as the First Manifestation of Light-chain Amyloidosis.
Öztürk E; Akay MO; Ferhanoğlu B
Turk J Haematol; 2018 Aug; 35(3):208-209. PubMed ID: 29553461
[No Abstract] [Full Text] [Related]
10. New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation.
Girnius S; Seldin DC; Cibeira MT; Sanchorawala V
J Clin Oncol; 2013 Jul; 31(21):2749-50. PubMed ID: 23775968
[No Abstract] [Full Text] [Related]
11. Reply to S. Girnius et al.
Palladini G; Dispenzieri A; Gertz M; Kumar S; Wechalekar A; Hawkins PN; Schönland S; Hegenbart U; Comenzo R; Kastritis E; Dimopoulos MA; Jaccard A; Klersy C; Merlini G
J Clin Oncol; 2013 Jul; 31(21):2750-1. PubMed ID: 24040662
[No Abstract] [Full Text] [Related]
12. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
[TBL] [Abstract][Full Text] [Related]
13. Light-chain (AL) amyloidosis: diagnosis and treatment.
Sanchorawala V
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366
[TBL] [Abstract][Full Text] [Related]
14. Immunofixation electrophoresis was highly specific for the diagnosis of renal light-chain amyloidosis.
Zhou FD; Zhang LX; Yao Y; Wang SX; Zou WZ; Liu G; Chen M; Zhao MH
Am J Med Sci; 2013 Jan; 345(1):18-21. PubMed ID: 22627261
[TBL] [Abstract][Full Text] [Related]
15. Eprodisate in amyloid A amyloidosis: a novel therapeutic approach?
Manenti L; Tansinda P; Vaglio A
Expert Opin Pharmacother; 2008 Aug; 9(12):2175-80. PubMed ID: 18671471
[TBL] [Abstract][Full Text] [Related]
16. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.
Palladini G; Dispenzieri A; Gertz MA; Kumar S; Wechalekar A; Hawkins PN; Schönland S; Hegenbart U; Comenzo R; Kastritis E; Dimopoulos MA; Jaccard A; Klersy C; Merlini G
J Clin Oncol; 2012 Dec; 30(36):4541-9. PubMed ID: 23091105
[TBL] [Abstract][Full Text] [Related]
17. [Amyloidosis in rheumatic diseases].
Zdrojewski Z
Ann Acad Med Stetin; 2010; 56 Suppl 1():7-15. PubMed ID: 21365934
[TBL] [Abstract][Full Text] [Related]
18. Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.
Graziani MS; Merlini G
Expert Rev Mol Diagn; 2014 Jan; 14(1):55-66. PubMed ID: 24308339
[TBL] [Abstract][Full Text] [Related]
19. The challenge of systemic immunoglobulin light-chain amyloidosis (Al).
Palladini G; Comenzo RL
Subcell Biochem; 2012; 65():609-42. PubMed ID: 23225018
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.
Abraham RS; Katzmann JA; Clark RJ; Bradwell AR; Kyle RA; Gertz MA
Am J Clin Pathol; 2003 Feb; 119(2):274-8. PubMed ID: 12579999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
